Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TRLV · against 352 other Healthcare companies of similar size
Ranked #297 of 353 · scores higher than 16% of peers
Bars: peers in each 10-point band of the growth score43 peers with a growth score of 20–29, including TRLV · Click a bar to see the companies
Mainly because of its earnings per share growth, revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | TRLV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 353 reported | -3.9% | 6.8% | 19% | 33% | |
| Earnings per share growthHigher is better · 203 reported | Not reported | 10.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 345 reported | -0.6% | 8.2% | 24% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 293 | 10.4B CNY (≈$1.5B) | 22 | 42 | |
| 293 | 1.7B USD | 22 | 44 | |
| 293 | 1.9B USD | 22 | 38 | |
| 297 | 10.6B CNY (≈$1.5B) | 21 | 43 | |
| 297 | 2.2B USD | 21 | 23 | |
| 299 | 9.6B CNY (≈$1.3B) | 20 | 27 | |
| 299 | 22.3B SEK (≈$2.2B) | 20 | 36 | |
| 301 | 9.9B CNY (≈$1.4B) | 19 | 50 | |
| 301 | 1.2B USD | 19 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score